Results 41 to 50 of about 8,350 (244)

Optimal protection of stabilised dry live bacteria from bile toxicity in oral dosage forms by bile acid adsorbent resins [PDF]

open access: yes, 2010
We previously found that dried live bacteria of a vaccine strain can be temporarily sensitive to bile acids and suggested that Bile Adsorbing Resins (BAR) can be used in oral vaccine tablets to protect dried bacteria from intestinal bile. Here, we report
Chatterjee, Pratichi   +4 more
core   +1 more source

Targeted colonic release formulations of mesalazine - A clinical pharmaco-scintigraphic proof-of-concept study in healthy subjects and patients with mildly active ulcerative colitis. [PDF]

open access: yes, 2022
Colonic targeting of orally applied therapeutic drugs remains a challenge. Tablet coatings relying on gastrointestinal pH and colonic bacterial enzymes as triggers in association with an inner alkaline layer are expected to improve targeting efficiency ...
Bravo, R   +8 more
core   +1 more source

Pharmacokinetics and Pharmacodynamics during Treatment with the Omeprazole 20 mg Enteric-Coated Tablet and 20 mg Capsule in Asymptomatic Duodenal Ulcer Patients

open access: yesCanadian Journal of Gastroenterology, 1997
This study compared the 24 h intragastric pH profile and bioavailability at repeated dosing conditions of the omeprazole 20 mg enteric-coated tablet versus the 20
ABR Thomson   +5 more
doaj   +1 more source

In Vitro Evaluation of Eslicarbazepine Delivery via Enteral Feeding Tubes [PDF]

open access: yes, 2017
Purpose: The feasibility of preparing an eslicarbazepine acetate suspension using Aptiom tablets for administration via enteral feeding tubes was evaluated.
Dave, Vivek S   +3 more
core   +2 more sources

Influence of Food on the Bioavailability of an Enteric-Coated Tablet Formulation of Omeprazole 20 mg Under Repeated Dose Conditions

open access: yesCanadian Journal of Gastroenterology, 1997
The objective of this study was to investigate the influence of food on the bioavailability of omeprazole (20 mg) given as an enteric-coated tablet under repeated dose
ABR Thomson   +5 more
doaj   +1 more source

Preformulation and preliminary formulation studies of mesalazine gastro-resistant tablets [PDF]

open access: yesRomanian Journal of Pharmaceutical Practice, 2020
Mesalamine, 5-aminosalicylic acid or mesalazine is the standard therapy of inflammatory bowel disease. A small number of pharmaceutical dosage forms with mesalazine are on the market.
Adriana Aurelia Chiş   +5 more
doaj   +1 more source

Uji Bioavailabilitas Tablet Floating Aspirin [PDF]

open access: yes, 2017
Aspirin is a non-steroidal anti-inflammatory drug with potential as antiplatelet for stroke prophylaxis. Several approaches of aspirin formulations in various dosage forms have been performed.
Fudholi, Achmad   +3 more
core   +3 more sources

In Vivo Evaluation of a Gastroretentive Drug Delivery System Based on Enteric-Coated Floating Tablets [PDF]

open access: yes, 2015
Floating dosage forms are supposed to exhibit an enhanced gastric residence time. Their development is challenging as the prediction of the retention potential in humans based on in vitro studies and animal models is difficult.
Alles, Rainer   +4 more
core   +1 more source

A NOVEL APPROACH IN DESIGNING ENTERIC-COATED ANTIPLATELET DRUG FOR BYPASSING STOMACH AND GASTRIC IRRITATION [PDF]

open access: yes, 2020
Objective: The innovative approach in this investigation is making an enteric-coated acetylsalicylic acid (ASA) for antiplatelet activity using a novel excipient. Methods: A novel methodology used in making ASA tablets for tackling the stomach irritation
CHANDRA SEKHAR, KOTHAPALLI BANOOTH   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy